Development of Adenoviral Vectors That Transduce Purkinje Cells and Other Cerebellar Cell-Types in the Cerebellum of a Humanized Mouse Model

To overcome the current limitations of Adenoviral vectors (Ad) to treat central nervous system disorders, scientists created chimeric 1st generation Ad vectors that utilize the human CD46 receptor.